Mar 24, 2020

Royal Commission Extends Deadline For Submissions

In a recent media release, The Royal Commission into Aged Care Quality and Safety has revealed that they will suspend all hearings and workshops, for the time being, subject to ongoing review.

This decision is a consequence of the evolving coronavirus (COVID-19) pandemic, and based on information available from the Australian Government and affects all hearings and workshops scheduled until at least the end of May 2020.

The suspension also applies to all group consultations which have been part of the engagement work conducted by Royal Commission staff.

The Commissioners are considering the implications of this decision on the continuing work program of the Royal Commission.

Given the continuing effects of the COVID-19 pandemic, the deadline for submissions is subject to continual monitoring.

For more information read the media release and visit the about the Coronavirus and the Aged Care Royal Commission page.

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

$17.5 Billion of Taxpayer’s Money Spent on Aged Care Services: Money Well Spent?

Aged care is becoming more of an inevitable future for many Australians. We’re living longer and developing more complex health conditions needing extra assistance at home and in aged care. But are you aware of how much of the tax payers money is spent on aged care?  or exactly how many aged care workers are in... Read More

Doctors Are Leaving Aged Care Facilities In Droves, Why?

  It is important to note the contextual statistics that are at play when discussing matters of aged care, reform and an exodus of doctors from the sector. In light of the statistical facts, the issues and pressures on the aged care sector are only going to grow. There is no other way to read... Read More

Australian first program supports Victorian cancer patients’ access to precision medicine

Access to cutting edge personalised cancer treatments and the sharing of genetic testing information to further improve treatments are among the aims of a new Monash Partners Comprehensive Cancer Consortium (MPCCC)-led program. Read More
Advertisement
Exit mobile version